Preclinical study of dimebon on b-amyloid-mediated neuropathology in Alzheimer’s disease

Jun Wang1,2, Mario G Ferruzzi3, Merina Varghese1,2, Xianjuan Qian1, Alice Cheng1, Mathew Xie1, Wei Zhao1,Lap Ho1, Giulio M Pasinetti1,2,4,5*

Sources: 1Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029 USA. 2Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029 USA. 3Departments of Food Science and Foods&Nutrition, Purdue University, West Lafayette, Indiana 47907 USA.4Department of Neuroscience, Mount Sinai School of Medicine, New York, New York 10029 USA. 5Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York 10468 USA.

Molecular Neurodegeneration 2011; 6: 7. Published online 2011 January 19. doi: 10.1186/1750-1326-6-7.http://www.molecularneurodegeneration.com/content/6/1/7